MS Case Study
Multi-country, multi-product, end-to-end patient support for Multiple Sclerosis
The customer engaged RxPx to support Multiple Sclerosis (MS) patients on therapy. RxPx addressed multiple challenges across several markets, including patient onboarding requirements and treatment adherence. The program provided pre-screening, dose, and adherence support through a personalized patient support portal.
The Challenge
The global pharmaceutical customer maintains a portfolio of several MS products, each with unique routes of administration and patient journey challenges that vary by country.
- Several products face complex titration portfolios
and a lack of patient confidence when it comes to
self-injecting. - Rural/remote patients were also unable to access face-to-face care.
- National payer requirements slowed down product uptake.
- Patients required first-dose observation and
titration navigation.
Click to read the full case study and find out about how
RxPX powered this major global pharma brand to launch
a private, personalized app-based patient community
The Results
%
74% faster time to
treatment, shortened from
~6 weeks to 11-16 days
%
90%* average adherence rates
across the MS drugs in PSP
%
92% patient
satisfaction rating
‘”We’ve had really great feedback from patients in regard to the service and the whole program in general, so thanks for making patient transitions onto medication so smooth, it s been really amazing.” – HCP
“Thank you, I really appreciate all of your help. I can’t say enough, you have been amazing. I’m going to tell my Neurologist about this because everyone should be able to use the program.” – Patient
For every 3 minutes it takes to enroll a patient, it saves 3 hours.” – HCP
